BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 20541775)

  • 1. Fingolimod Increases Brain-Derived Neurotrophic Factor Level Secretion from Circulating T Cells of Patients with Multiple Sclerosis.
    Golan M; Mausner-Fainberg K; Ibrahim B; Benhamou M; Wilf-Yarkoni A; Kolb H; Regev K; Karni A
    CNS Drugs; 2019 Dec; 33(12):1229-1237. PubMed ID: 31713782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17 and limits of success.
    Omidian Z; Ahmed R; Giwa A; Donner T; Hamad ARA
    Cell Immunol; 2019 May; 339():33-40. PubMed ID: 30765202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD40-CD40L Dyad in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
    Aarts SABM; Seijkens TTP; van Dorst KJF; Dijkstra CD; Kooij G; Lutgens E
    Front Immunol; 2017; 8():1791. PubMed ID: 29312317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of macrophage phenotype by mature and pro-nerve growth factor.
    Williams KS; Killebrew DA; Clary GP; Seawell JA; Meeker RB
    J Neuroimmunol; 2015 Aug; 285():76-93. PubMed ID: 26198923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and lymphocytic neurotrophins profiles in systemic lupus erythematosus: a case-control study.
    Fauchais AL; Lise MC; Marget P; Lapeybie FX; Bezanahary H; Martel C; Dumonteil S; Sparsa A; Lalloué F; Ly K; Essig M; Vidal E; Jauberteau MO
    PLoS One; 2013; 8(11):e79414. PubMed ID: 24223945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD11b+GR1+ myeloid cells secrete NGF and promote trigeminal ganglion neurite growth: implications for corneal nerve regeneration.
    Sarkar J; Chaudhary S; Jassim SH; Ozturk O; Chamon W; Ganesh B; Tibrewal S; Gandhi S; Byun YS; Hallak J; Mahmud DL; Mahmud N; Rondelli D; Jain S
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):5920-36. PubMed ID: 23942970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced ErbB4 Expression in Immune Cells of Patients with Relapsing Remitting Multiple Sclerosis.
    Tynyakov-Samra E; Auriel E; Levy-Amir Y; Karni A
    Mult Scler Int; 2011; 2011():561262. PubMed ID: 22096639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of neurotrophins in multiple sclerosis-pathological and clinical implications.
    Kalinowska-Lyszczarz A; Losy J
    Int J Mol Sci; 2012 Oct; 13(10):13713-25. PubMed ID: 23202976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated neurotrophin mRNA production by immune cells of patients with relapsing remitting multiple sclerosis.
    Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Farhum F; Karni A
    J Neurol Sci; 2010 Aug; 295(1-2):31-7. PubMed ID: 20541775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.
    Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Bornstein NM; Karni A
    J Neuroimmunol; 2011 Mar; 232(1-2):171-8. PubMed ID: 21111488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low and dysregulated production of follistatin in immune cells of relapsing-remitting multiple sclerosis patients.
    Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Karni A
    J Neuroimmunol; 2011 Sep; 238(1-2):96-103. PubMed ID: 21880375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-beta therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism.
    Azoulay D; Mausner-Fainberg K; Urshansky N; Fahoum F; Karni A
    J Neuroimmunol; 2009 Jun; 211(1-2):114-9. PubMed ID: 19419774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
    Hamamcioglu K; Reder AT
    Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection.
    Azoulay D; Urshansky N; Karni A
    J Neuroimmunol; 2008 Mar; 195(1-2):186-93. PubMed ID: 18329726
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.